MedTrace Logo

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

NCT03020719 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-01-09

Study results available
· View outcomes & findings →

Summary

The purpose of this randomized, placebo-controlled (Phase II) study will be to further evaluate the effects of oral glutathione on growth in children with CF.

Conditions

Interventions

DRUG

Oral Glutathione

Oral Glutathione oral powder

DRUG

Placebo

Placebo oral powder

Sponsors & Collaborators

Principal Investigators

  • Sarah J Schwarzenberg, MD · University of Minnesota

  • Molly Bozic, MD · Indiana University School of Medicine Riley Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2018-12-12
Completion
2018-12-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03020719 on ClinicalTrials.gov